Actively Recruiting

Age: 0 - 18Years
All Genders
Healthy Volunteers
ID04723654

Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients and Healthy Children Under 18

Led by Ann & Robert H Lurie Children's Hospital of Chicago · Updated on 2024-11-27

500

Participants Needed

2

Research Sites

25 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating biocompatible wireless electronic devices designed to continuously and non-invasively measure vital signs and physiological data in patients within the Intensive Care Unit (ICU) and in non-ICU pediatric populations. This observational study aims to compare data from these novel wearable sensors with standard monitoring devices to improve patient care in critical settings, particularly focusing on children under 18 years of age. The study is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago and includes patients from multiple ICUs and healthy volunteers who visit a pediatric autonomic medicine center. The study involves placing up to five wireless wearable vital sign monitors on ICU patients for up to 48 hours, attached to various body locations such as the chest, back, or limbs using medical-grade adhesives or hypoallergenic soft wrap-around devices. For non-ICU participants, these sensors are worn for up to three hours during a single outpatient visit. The devices continuously capture data including blood pressure, respiratory rate using bioimpedance, and skin temperature, while standard cuff-based blood pressure and skin temperature measurements are also recorded for comparison. Optional video monitoring of participant movement and position may be conducted with family consent. Participants undergo screening through medical record reviews or parent/guardian interviews depending on ICU or non-ICU status. Skin integrity is closely monitored before, during, and after sensor use using validated scales and photographs. Data from wearable sensors and standard monitoring systems are securely collected and stored for analysis. After the monitoring period, parents complete brief questionnaires about the devices. The primary outcome measures focus on continuous non-invasive blood pressure monitoring for up to 48 hours, with secondary outcomes assessing the accuracy of other physiological signals.

CONDITIONS

Brief Title

Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients

Who Can Participate

Age: 0 - 18Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Admitted to one of the four ICUs at Lurie Children's or Prentice Women's Hospital
  • Under 18 years of age
  • Willing to visit the Center for Autonomic Medicine in Pediatrics (CAMP) for a one-time study visit (non-ICU participants)
Not Eligible

You will not qualify if you...

  • Having a skin abnormality that increases risk with device use
  • Being 18 years of age or older
  • For ICU patients, being determined too unstable or under too much stress by medical staff

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Screening and enrollment visit

Implementation

Duration - Up to 48 hours for ICU participants; up to 3 hours for non-ICU participants

Participants have up to 5 wearable vital sign sensors placed on various body locations to continuously monitor vital signs. In ICU patients, devices are worn for up to 48 hours with checks at least every 24 hours to ensure skin integrity and signal quality. In non-ICU participants, sensors are worn for up to 3 hours during a single outpatient study visit. Standard care monitoring continues alongside wearable sensors.

1 to 2 visits depending on participant group

Long-term Monitoring

Duration - Up to 48 hours for ICU participants; up to 3 hours for non-ICU participants

Data from wearable sensors and standard care monitors are collected and compared. Skin integrity is assessed before and after device use, with additional assessments as needed. Optional video monitoring of participant movement and position may be performed during the study period.

Monitoring during device wear period; no additional visits

Follow-up

Duration - Single follow-up after device monitoring

Parents or guardians complete questionnaires to provide feedback on device use in the ICU. These questionnaires take less than 10 minutes and are completed after the study period ends.

1 follow-up visit or remote completion

Trial Site Locations

Total: 2 locations

1

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States, 60611

Actively Recruiting

2

Northwestern Medicine Prentice Women's Hospital

Chicago, Illinois, United States, 60611

Actively Recruiting

Loading map...

Research Team

S

Susan Slattery, MD

C

Casey Rand, MDS

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Azithromycin and Ampicillin for Late Preterm Premature Ruptu...

Pregnancy Complications, Infectious

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Skin-interfaced biosensors for advanced wireless physiological monitoring in neonatal and pediatric intensive-care units.

Ha Uk Chung, Alina Y Rwei, Aurélie Hourlier-Fargette...

https://pubmed.ncbi.nlm.nih.gov/32161411